ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 285 filers reported holding ROYALTY PHARMA PLC in Q2 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $3,953 | +40.2% | 130,188 | +25.3% | 0.02% | -14.3% |
| Q3 2023 | $2,820 | -74.7% | 103,916 | -71.4% | 0.03% | -73.1% |
| Q2 2023 | $11,150 | +135.7% | 362,739 | +203.1% | 0.10% | +55.2% |
| Q4 2022 | $4,730 | -99.8% | 119,689 | +98.5% | 0.07% | +139.3% |
| Q2 2022 | $2,534,000 | -80.1% | 60,283 | -80.6% | 0.03% | -76.1% |
| Q2 2021 | $12,743,000 | +273.8% | 310,887 | +342.6% | 0.12% | +14.7% |
| Q2 2020 | $3,409,000 | – | 70,234 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $263,446,000 | 59.92% |
| Memorial Sloan Kettering Cancer Center | 1,128,255 | $43,957,000 | 50.90% |
| Vantage Consulting Group Inc | 2,727,854 | $106,277,000 | 41.47% |
| Indie Asset Partners, LLC | 756,874 | $29,488,000 | 22.15% |
| Overbrook Management Corp | 723,250 | $28,178,000 | 6.25% |
| Brown University | 621,759 | $24,224,000 | 5.93% |
| Geo Capital Gestora de Recursos Ltd | 200,692 | $8,527,000 | 3.82% |
| Lagoda Investment Management, L.P. | 141,560 | $5,515,000 | 2.97% |
| Greytown Advisors Inc. | 131,143 | $5,109,000 | 2.47% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,025,610 | $78,918,000 | 2.41% |